Ensysce Biosciences ENSC
NASDAQ ENSC
$0.51 -0.01 (-1.73%)
At close: Oct 22, 2026 · 4:00 PM EDT

Ensysce Biosciences (ENSC) Long-Term Debt Issuances (2020 - 2021)

Updated

Ensysce Biosciences' Long-Term Debt Issuances was $1.61 million in FY2023, down 78.7% from $7.53 million in FY2022.

Analysis

Ensysce Biosciences (ENSC) Long-Term Debt Issuances (2020 - 2021) Analysis & Trends

From FY2017 onward, Ensysce Biosciences has reported Long-Term Debt Issuances for 6 years.

  • Long-Term Debt Issuances shows a four-year compound annual growth rate of 29.8% (FY2019 to FY2023).
  • The FY2023 figure marks the lowest annual Long-Term Debt Issuances since FY2020.
  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $7.53 million in FY2022 (-46.3%), $14.03 million in FY2021, $1 million in FY2020 (+76.6%) and $566,268 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Ensysce Biosciences 1.30 Mn -9.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 9.48 Mn
Sep 30, 2021 4.50 Mn
Jun 30, 2021 50,000.00
Mar 31, 2021 350,000.00
Sep 30, 2020 300,000.00
Jun 30, 2020 -200,000.00
Mar 31, 2020 1.00 Mn
API Access

Ensysce Biosciences Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ENSC&period=max&api_key=YOUR_API_KEY